Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51812 (
mitogen-activated protein
)
10,636
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Carcinoembryonic antigen-related cell adhesion molecule 1
(
CEACAM1
), an Ig-like transmembrane protein, functions in cell adhesion, angiogenesis and epithelial cell morphogenesis, and has been identified as a tumor suppressor. For all of these functions,
CEACAM1
requires signaling capabilities. However, the mechanisms of
CEACAM1
-mediated signaling are only poorly understood. Here we characterized for the first time
CEACAM1
expression and signaling in the neuroendocrine rat pheochromocytoma PC12 cell line. Stimulation of
CEACAM1
by ligation on the cell surface with antibodies induced formation of large
CEACAM1
clusters and a rapid and transient
CEACAM1
tyrosine dephosphorylation. Functionally, this dephosphorylation correlated with a reduced association between
CEACAM1
and the tyrosine phosphatase SHP2. Clustering also stimulated binding of
CEACAM1
to the actin cytoskeleton, measured by a partial translocation of
CEACAM1
into the insoluble fraction after detergent extraction. Both tyrosine dephosphorylation and interaction with the cytoskeleton were sensitive to neuronal differentiation of PC12 cells. The first detected downstream activation of the
mitogen-activated protein
kinases ERK1 and ERK2, but not of JNK or p38, describes a novel target of
CEACAM1
-mediated signaling and contributes to the understanding of how
CEACAM1
regulates cellular function.
...
PMID:Clustering-induced signaling of CEACAM1 in PC12 cells. 1210 45
Carcinoembryonic antigen-related cell adhesion molecule 1
(CEACAM1,
CD66a
) is a member of the immunoglobulin (Ig) superfamily, previously characterized as an adhesion and signaling molecule in epithelial, endothelial, and hematopoietic cells. Here, we show that the CEACAM1 isoform expression pattern is different in nonactivated and activated primary mouse B lymphocytes and that CEACAM1 influences B cell receptor complex-mediated activation. A CEACAM1-specific monoclonal antibody strongly triggered proliferation of mouse B cells when combined with surface IgM cross-linking. However, anti-CEACAM1 was not mitogenic when added alone. The proliferation was more pronounced and lasted longer as compared with other activators of B cells, such as anti-IgM in the presence of interleukin-4 or lipopolysaccharide. A similar, costimulatory effect was exerted by CEACAM1-expressing fibroblasts, indicating that homophilic CEACAM1-CEACAM1 cell-mediated binding is the physiological stimulus for CEACAM1-triggered B cell signaling. The anti-CEACAM1/anti-IgM-activated cells aggregated in a lymphocyte function-associated antigen-1-dependent manner. Furthermore, cells that were activated by anti-CEACAM1/anti-IgM secreted Ig but did not go through Ig class-switching. Anti-CEACAM1 induced phosphorylation of c-Jun N-terminal kinase (stress-activated protein kinase) but did not activate the extracellular signal-regulated kinase or p38
mitogen-activated protein
kinases.
...
PMID:CEACAM1 is a potent regulator of B cell receptor complex-induced activation. 1283 51